Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole dosing for intestinal helminths
NCT01192802Phase 4Completed
- Sponsor
- Albert Schweitzer Hospital
- Start
- Aug 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of albendazole in intestinal helminthiasis, sponsored by Albert Schweitzer Hospital. Started Aug 2010; status: completed.
02
Drugs
albendazole
03
Conditions
intestinal helminthiasis
Beyond the preview
Go deeper on NCT01192802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192802.